Ranjit Makar, MD
Gastroenterology · San Jose, CANPI 1083858997
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boston Scientific at 54.3% of the total. Reporting peaked in 2019 at $2,610 and has fallen 96.7% since, to $87 in 2024.
Across 126 payments — averaging $48.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Ovesco Endoscopy USA, Inc.$858
- AbbVie$392
- Johnson & Johnson$328
- Cook Medical LLC$295
- Gilead$185
- plus $729 from 12 others
What the payments were for
- Travel & lodging$3,50157%
- Food & beverage$2,50141%
- Education$1002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $3,316 |
| Ovesco Endoscopy USA, Inc. | 1 | $858 |
| AbbVie | 24 | $392 |
| Johnson & Johnson | 33 | $328 |
| Cook Medical LLC | 3 | $295 |
| Gilead | 7 | $185 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $156 |
| Nestle Healthcare Nutrition Inc. | 1 | $130 |
| Fujifilm Wako Diagnostics U.S.A. Corporation | 1 | $101 |
| QOL Medical, LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Ferring Pharmaceuticals Inc. | 3 | $48 |
| Intra-sana Laboratories | 1 | $42 |
| Redhill Biopharma Inc. | 2 | $40 |
| Eisai Inc. | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $16 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,102 in reported general payments places this provider in the 70th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 99 | $2,217 |
| Pantoprazole Sodium | 83 | $711 |
| Ciprofloxacin Hcl | 30 | $212 |
| Omeprazole | 12 | $113 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Jose
- Suejin KimSan Jose$231K
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
- Sadeea AbbasiLos Angeles$556K
- Ali RezaieWest Hollywood$519K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.